RECRUITING

Discovering Factors in the Clinical Study Journey of Patients With OCD

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This research aims to collect comprehensive data on the clinical trial experience of OCD patients. Its goal is to identify the factors that limit patients' ability to join or complete a trial successfully. Clinical trial participation often favors specific demographic groups, and limited research exists on the impact of trial attributes on participation. Therefore, this study aims to analyze data from various demographic groups and identify any recurring trends that could provide valuable insights for future OCD patients.

Official Title

Understanding the Patient Perspective: An Observational Study on Experiences of OCD Clinical Trial Patients

Quick Facts

Study Start:2024-06
Study Completion:2026-06
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05881356

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed.
  2. * Participant has a diagnosis of OCD.
  3. * Willing and able to comply with scheduled visits, treatment schedule, laboratory tests and other requirements of the study.
  1. * Pregnant or lactating woman
  2. * Enrolled in another research study
  3. * Any mental or medical condition that prevents the patient from giving informed consent or participating in the trial

Contacts and Locations

Study Contact

Michael B Gill
CONTACT
415-900-4227
bask@withpower.com

Principal Investigator

Michael B Gill
STUDY_DIRECTOR
Power Life Sciences Inc.

Study Locations (Sites)

Power Life Sciences
San Francisco, California, 94107
United States

Collaborators and Investigators

Sponsor: Power Life Sciences Inc.

  • Michael B Gill, STUDY_DIRECTOR, Power Life Sciences Inc.

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-06
Study Completion Date2026-06

Study Record Updates

Study Start Date2024-06
Study Completion Date2026-06

Terms related to this study

Keywords Provided by Researchers

  • OCD
  • Obsessive-Compulsive Disorder

Additional Relevant MeSH Terms

  • OCD
  • Obsessive-Compulsive Disorder